Costs Inc / Hologic / GE / Intervention Mean Costs Mean QALYs Inc / /
Continent
Australia / /
Country
Australia / /
Currency
USD / / /
Event
Product Issues / /
Facility
Australian Institute of Health / Griffith University / /
Holiday
Commonwealth Day / Commonwealth Day of Australia / /
IndustryTerm
clinical decision algorithm / treatment for early breast cancer / therapy for osteoporosis / clinical algorithm / health technology reports / treatment for breast cancer / breast cancer patients receiving aromatase inhibitor treatment Internet / imaging / Anti-resorptive combination products / breast cancer treatment / energy / metal / healthcare system / osteoporosis prevention / /
MedicalCondition
breast cancer AI / ovarian cancers / osteoclast-mediated bone resorption / early breast cancer / skin cancer / heart disease / muscle weakness / premature menopause / fatigue / skeletal metastases / early stage breast cancer / bone resorption / osteopenia and normal BMD / infections / breast cancer / osteopenia / osteoporosis T-score / cancers / established osteoporosis / cancer / disease / arthralgia / hot flushes / dull ache / vitamin D deficiency / fever / bone disease / pain / deep vein thrombosis / post-menopausal osteoporosis / osteoporosis / chronic diseases / joint pain / /
MedicalTreatment
endocrine therapy / chemotherapy / surgery / Radiation / /
Organization
World Health Organization / Australian Government / Health Expert Standing Panel / Medicare / Australian and New Zealand Bone Mineral Society / Griffith University / Department of Health / Medical Services Advisory Committee / Australian Institute of Health / /
Person
Background Women / /
Position
Minister / accredited specialist / physician / consultant physician / nuclear medicine physician / General / Governor / Executive / Major / representative / specialist physician / Marshall / /
MSAC application no 1313 Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment June 2014